Related Experiment Video
Updated: Apr 22, 2026
Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR
Published on: January 22, 2014
Identification of a set of endogenous reference genes for miRNA expression studies in Parkinson's disease blood
Alice Serafin, Luisa Foco, Hagen Blankenburg
1Center for Biomedicine, European Academy Bozen/Bolzano (EURAC), 39100 Bolzano, Italy, Affiliated Institute of the University of Lübeck, Lübeck, Germany. christine.schwienbacher@eurac.edu.
Background:
Research on microRNAs (miRNAs) is becoming an increasingly attractive field, as these small RNA molecules are involved in several physiological functions and diseases. To date, only few studies have assessed the expression of blood miRNAs related to Parkinson's disease (PD) using microarray and quantitative real-time PCR (qRT-PCR). Measuring miRNA expression involves normalization of qRT-PCR data using endogenous reference genes for calibration, but their choice remains a delicate problem with serious impact on the resulting expression levels. The aim of the present study was to evaluate the suitability of a set of commonly used small RNAs as normalizers and to identify which of these miRNAs might be considered reliable reference genes in qRT-PCR expression analyses on PD blood samples.
Results:
Commonly used reference genes snoRNA RNU24, snRNA RNU6B, snoRNA Z30 and miR-103a-3p were selected from the literature. We then analyzed the effect of using these genes as reference, alone or in any possible combination, on the measured expression levels of the target genes miR-30b-5p and miR-29a-3p, which have been previously reported to be deregulated in PD blood samples.
Conclusions:
We identified RNU24 and Z30 as a reliable and stable pair of reference genes in PD blood samples.
Insights
This study identifies reliable reference genes for Parkinson's disease (PD) blood sample analysis. RNU24 and Z30 are validated as stable normalizers for accurate microRNA expression quantification in PD research.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- MicroRNAs (miRNAs) play crucial roles in physiological functions and diseases, including Parkinson's disease (PD).
- Accurate quantification of miRNA expression in PD blood samples using quantitative real-time PCR (qRT-PCR) relies on appropriate normalization with reference genes.
- The selection of suitable reference genes is critical but challenging, significantly impacting expression level results.
Purpose of the Study:
- To evaluate the suitability of commonly used small RNAs as normalizers for qRT-PCR analysis in PD blood samples.
- To identify reliable reference genes for accurate miRNA expression studies in Parkinson's disease.
Main Methods:
- Selection of candidate reference genes (RNU24, RNU6B, Z30, miR-103a-3p) from existing literature.
- Analysis of the impact of these genes, individually and in combination, on the expression levels of target miRNAs (miR-30b-5p, miR-29a-3p).
- Utilized quantitative real-time PCR (qRT-PCR) for miRNA expression analysis.
Main Results:
- Evaluated the stability of RNU24, RNU6B, Z30, and miR-103a-3p as potential reference genes.
- Assessed the influence of different normalization strategies on the expression levels of miR-30b-5p and miR-29a-3p in PD blood.
- Identified specific small RNAs demonstrating stable expression patterns.
Conclusions:
- RNU24 and Z30 were identified as a reliable and stable pair of reference genes.
- This pair is recommended for accurate normalization in qRT-PCR-based miRNA expression studies of Parkinson's disease blood samples.
More Related Videos
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
13:36Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
Related Concept Videos
01:37Neural Regulation
01:24Parkinson Disease l: Introduction